Please Wait
Applying Filters...
menu
    • menu
    Nanoalvand-PSE
    News
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy

    17 Apr 2025

    // PRESS RELEASE

    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    NanoAlvand VB RM

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
    Left Arrow
    Right Arrow

    NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Related CompaniesRelated Companies

    About

    NanoAlvand©, founded in 2011, is a premier pharmaceutical company dedicated to producing high-quality medications with a primary focus on oncology, rheumatology & neurology. We offer liquid, solid, and semi-solids-designed to meet diverse therapeutic needs & strong export ties across the Middle East, EAEU, and ASEAN, we are actively expanding into new international markets. Committed to quality, compliance & continuous innovation, we collaborate with top global suppliers and pursue strategic partnerships through joint ventures and technology transfer. We welcome suppliers, manufacturers, & distributors to join us-Our Hope Shapes The Future.